Resting Tremor
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Darkness Tremor
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Tremor, Perioral
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Tremor, Limb
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Tremor, Muscle
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Nerve Tremors
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Tremor, Neonatal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Pill Rolling Tremor
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Tremor, Semirhythmic
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Involuntary Quiver
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
|
9920179 |
1999 |
Heart failure
|
0.200 |
Biomarker
|
disease |
RGD |
Regulation of neuronal type genes in congestive heart failure rats.
|
16497176 |
2006 |
Congestive heart failure
|
0.200 |
Biomarker
|
disease |
RGD |
In CHF hearts, the expression of the muscarinic m4 (Chrm4) and nicotinic alpha4 (Chrna4) acetylcholin receptors, the ATP receptor P2rx4, nerve growth factor receptor (Ngfr), discoidin domain receptor 1 (Ddr1), neuronal pentraxin receptor (Nptxr), peripheral myelin protein Pmp-22, leukocyte type 12-lipoxygenase (Alox15), cytochrome P450 4F5 (Cyp4F5) and cardiac Kcne1 were all increased (range 1.6-6.0-fold, P < 0.01 for all genes).
|
16497176 |
2006 |
MYELODYSPLASTIC SYNDROME
|
0.010 |
Biomarker
|
group |
BEFREE |
Here, we found that the muscarinic acetylcholine receptor, cholinergic receptor, muscarinic 4 (CHRM4), pathway regulates BFU-E self-renewal and that pharmacological inhibition of CHRM4 corrects anemias of myelodysplastic syndrome (MDS), aging, and hemolysis.
|
31554738 |
2019 |
Cocaine Dependence
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Of the 20 SNPs that showed nominally significant associations, the association of the African-specific CHRM4 SNP rs2229163 (Asn417=) with cocaine dependence survived correction for multiple testing (Pcorrected = 0.047).
|
27269905 |
2016 |
Mental disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
These findings led us to determine whether variation in the CHRM4 gene sequence was associated with an altered risk of schizophrenia by sequencing the CHRM4 gene from the brains of 76 people with the disorder and 74 people with no history of psychiatric disorders.
|
23490763 |
2013 |
Abnormal behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
These findings led us to determine whether variation in the CHRM4 gene sequence was associated with an altered risk of schizophrenia by sequencing the CHRM4 gene from the brains of 76 people with the disorder and 74 people with no history of psychiatric disorders.
|
23490763 |
2013 |